Abstract
We performed a study of the two clinical entities with a differential diagnosis with wet age-related macular degeneration, namely, idiopathic polypoidal choroidal vasculopathy (IPCV) and retinal angiomatous proliferation. We analyze the clinical and funduscopic characteristics of these entities as well as their differences with wet age-related macular degeneration. We present two cases that are representative of these two entities. The therapeutic possibilities, results and the latest publications are analyzed and compared. A statistical analysis of the latest publications is also presented.
Copyright © 2012 Sociedad Española de Oftalmología. Published by Elsevier Espana. All rights reserved.
Publication types
-
Case Reports
-
English Abstract
-
Review
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Aged
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Bevacizumab
-
Capillaries / drug effects
-
Capillaries / pathology
-
Choroid / blood supply
-
Choroidal Neovascularization / drug therapy*
-
Choroidal Neovascularization / surgery
-
Combined Modality Therapy
-
Fluorescein Angiography
-
Humans
-
Laser Coagulation
-
Male
-
Ophthalmoscopy
-
Photochemotherapy
-
Ranibizumab
-
Retinal Vessels / drug effects
-
Retinal Vessels / pathology
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vascular Endothelial Growth Factor A / physiology
-
Wet Macular Degeneration / classification
-
Wet Macular Degeneration / drug therapy*
-
Wet Macular Degeneration / pathology
-
Wet Macular Degeneration / surgery
Substances
-
Adrenal Cortex Hormones
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Bevacizumab
-
Ranibizumab